Ranbaxy turns profitable on forex gain, Q3 net at Rs 754cr

Ranbaxy Laboratories  , a subsidiary of Daiichi Sankyo of Japan, has reported a consolidated net profit of Rs 754 crore in the third quarter of current calendar year as against loss of Rs 464 crore in the corresponding quarter of last fiscal due to forex gain.

Consolidated net sales rose by 31 percent year-on-year to Rs 2,651 crore during the same quarter.

Other income increased significantly to Rs 66 crore in the quarter ended September 2012 from Rs 28.5 crore in a year ago period.

Ranbaxy Labs has reported total foreign exchange gain of Rs 461.7 crore during July-September period.